Solid Biosciences Inc.
SLDB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001707502
No open-market purchases or sales by Solid Biosciences Inc. insiders were filed in the last 90 days; 157 institutions reported holding it in 13F filings for Q2 2026, worth $1.14B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Solid Biosciences Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- +4 vs. Q4 2022
- Shares held
- 15.8M
- +464.7K (+3.0%) vs. Q4 2022
- Total value
- $74.8M
- −$10.9M (−12.7%) vs. Q4 2022
- New holders
- 10
- 8 more added
- Sold out
- 6
- 9 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLDB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 157 | $1.14B |
| Q1 2026 | 150 | $717.4M |
| Q4 2025 | 132 | $459.2M |
| Q3 2025 | 129 | $505.2M |
| Q2 2025 | 116 | $403.4M |
| Q1 2025 | 125 | $293.2M |
| Q4 2024 | 90 | $145.3M |
| Q3 2024 | 92 | $249.8M |
| Q2 2024 | 80 | $213.2M |
| Q1 2024 | 56 | $465.9M |
| Q4 2023 | 40 | $102.2M |
| Q3 2023 | 37 | $40.7M |
| Q2 2023 | 36 | $85.6M |
| Q1 2023 | 39 | $74.8M |
| Q4 2022 | 35 | $85.6M |
| Q3 2022 | 58 | $33.4M |
| Q2 2022 | 67 | $39.5M |
| Q1 2022 | 78 | $83.3M |
| Q4 2021 | 82 | $132.2M |
| Q3 2021 | 91 | $184.3M |
| Q2 2021 | 92 | $293.4M |
| Q1 2021 | 104 | $437.6M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Solid Biosciences Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 3,495,933 | $16.6M | 0.49% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 3,426,286 | $16.2M | 0.37% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 3,130,422 | $14.8M | 1.85% | 00.0% | Unchanged |
| Camber Capital Management LP | 1,418,439 | $6.72M | 0.23% | 00.0% | Unchanged |
| Laurion Capital Management LP | 928,169 | $4.40M | 0.20% | 00.0% | Unchanged |
| Artal Group S.A. | 909,219 | $4.31M | 0.26% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 646,604 | $3.06M | 0.03% | +106,457+19.7% | Added |
| Finepoint Capital LP | 488,857 | $2.32M | 0.89% | +270,295+123.7% | Added |
| Caas Capital Management LP | 244,518 | $1.16M | 0.38% | −39,169−13.8% | Reduced |
| Pura Vida Investments, LLC | 224,902 | $1.07M | 0.11% | +224,902 | New |
| Vanguard Group Inc | 222,697 | $1.06M | 0.00% | 00.0% | Unchanged |
| Great Point Partners LLC | 210,405 | $997.3K | 0.20% | +210,405 | New |
| BlackRock Inc. | 138,761 | $657.7K | 0.00% | −5,303−3.7% | Reduced |
| Dimensional Fund Advisors LP | 56,335 | $267.0K | 0.00% | +597+1.1% | Added |
| Geode Capital Management, LLC | 41,911 | $198.7K | 0.00% | +2,830+7.2% | Added |
| Renaissance Technologies LLC | 38,763 | $184.0K | 0.00% | −13,000−25.1% | Reduced |
| Bridgeway Capital Management, LLC | 34,686 | $164.4K | 0.00% | +15,000+76.2% | Added |
| Tower Research Capital LLC (TRC) | 23,950 | $113.0K | 0.00% | +12,099+102.1% | Added |
| Susquehanna International Group, LLP | 18,690 | $88.6K | 0.00% | +18,690 | New |
| State Street Corp | 13,394 | $63.5K | 0.00% | −9,253−40.9% | Reduced |
| CIBC Asset Management Inc | 12,083 | $57.3K | 0.00% | +12,083 | New |
| Citadel Advisors LLC | 11,756 | $55.7K | 0.00% | +11,756 | New |
| Northern Trust Corp | 11,062 | $52.4K | 0.00% | +11,062 | New |
| Charles Schwab Investment Management Inc | 10,000 | $47.4K | 0.00% | +10,000 | New |
| Morgan Stanley | 4,618 | $21.9K | 0.00% | −69−1.5% | Reduced |
| Barclays PLC | 4,417 | $20.9K | 0.00% | −20−0.5% | Reduced |
| Bank of America Corp | 2,326 | $11.0K | 0.00% | −397−14.6% | Reduced |
| Lazard Asset Management LLC | 2,089 | $9.00K | 0.00% | +2,089 | New |
| Manchester Capital Management LLC | 1,000 | $4.74K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 300 | $1.42K | 0.00% | +300 | New |
| Group One Trading, L.P. | 274 | $1.30K | 0.00% | −13−4.5% | Reduced |
| Royal Bank of Canada | 254 | $1.00K | 0.00% | −70−21.6% | Reduced |
| JPMorgan Chase & Co | 133 | $1.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 166 | $787 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 158 | $748 | 0.00% | +128+426.7% | Added |
| First Manhattan Co | 133 | $630 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 123 | $583 | 0.00% | +29+30.9% | Added |
| Baker Avenue Asset Management, LP | 66 | $313 | 0.00% | +66 | New |
| Parallel Advisors, LLC | 6 | $28 | 0.00% | 00.0% | Unchanged |
| K2 Principal Fund, L.P. | 0 | $0 | 0.00% | −342,271−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −12,846−100.0% | Sold out |
| Old Well Partners, LLC | 0 | $0 | 0.00% | −10,800−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −9,507−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −1,367−100.0% | Sold out |
| Investors Research Corp | 0 | $0 | 0.00% | −13−100.0% | Sold out |